This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Director David Abrams Sells $19.7M Worth of Crown Castle

Stocks in this article: CCI

NEW YORK ( TheStreet) -- Which insiders are selling and buying chunks of stocks?

Below are lists of the top 10 open-market insider purchases and sales filed at the Securities and Exchange Commission Wednesday as ranked by dollar value. Company executives and directors are in the best position to assess the attractiveness of their firms' shares, and here is how many of them are voting their wallets! Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction.

Avigen (AVGN) Burlingame Asset Management LLC BO 1,461,729 $1,967,028
White Electronic Designs (WEDC) Desert Equity LP BO 401,041 $1,751,310
Delek Us Holdings (DK) Delek Petroleum Ltd BO 122,971 $723,829
Lime Energy (LIME) Kiphart Richard P DIR,BO 106,308 $414,442
Penseco Financial Services (PFNS) Keisling James G DIR 11,288 $352,680
CACI International (CACI) England Gordon R DIR 5,000 $235,575
Apollo Commercial RE Finance (ARI) Abbey Douglas D DIR 10,000 $178,600
Fifth Street Finance (FSC) Tannenbaum Leonard M CEO,PR,
DIR
10,000 $102,500
Hyperdynamics (HDY) Owen David DIR 92,604 $91,155
Taylor Capital Group (TAYC) Conte Randall CFO,COO 10,000 $78,172
Carefusion (CFN) Cardinal Health Inc BO 4,170,535 $101,750,399
Crown Castle Intl (CCI) Abrams David C DIR 537,369 $19,728,321
China Automotive Sys (CAAS) Qizhou Wu CEO,DIR 236,375 $4,838,926
Sunesis Pharmaceuticals (SNSS) Alta Biopharma Partners III LP BO 2,232,464 $4,485,914
Guess (GES) Marciano Maurice CB,DIR,
BO
100,000 $4,421,500
Global Defense Tech (GTEC) Perl Andrew Damian DIR,BO 236,726 $3,077,438
Vanda Pharmaceuticals (VNDA) Karabelas Argeris N DIR 228,924 $2,539,332
Martin Marietta Materials (MLM) Phoebe Snow Foundation O 28,600 $2,488,347
Marriott International (MAR) Marriott J W Jr CB,CEO,
DIR,BO
80,000 $2,160,000
Sothebys (BID) Ruprecht William F CEO,PR,
DIR
96,667 $2,114,068

Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,872.55 +44.80 0.25%
S&P 500 2,072.98 +0.15 0.01%
NASDAQ 4,808.0570 +20.74 0.43%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs